Articles

Recent studies show one-quarter of the population over the age of 75 who have type 2 diabetes are tightly managed with medications and are high risk for hypoglycemia.

SGLT shown as useful adjunctive agent when insulin monotherapy fails, but decrease in insulin use may prove harmful.

Scientists find dramatic weight loss may reverse type 2 diabetes in some patients.

Elevated eGR fund to possibly lead to renal damage.

Even as 2nd-line drugs, sulfonylureas shown to be cardiotoxic with high rate of low blood glucose

Patients who have normoglycemia still at risk for glucose spikes and diabetes.

Study investigates preservation or improvement of B-cell function using metformin with or without short-term insulin.

Guest Post by David Kliff, Editor, Diabetic Investor
This weekend, the most dedicated people in diabetes will gather in Baltimore for the AADE conference. Year after year, these amazing people gather to see all the latest toys in the toy chest, learn about all the new drugs, and share insights into how they are impacting the lives of the patients they work with.

New study finds late onset diabetes early sign of pancreatic cancer; African Americans with type 2 diabetes mellitus (T2DM) at a higher risk of developing pancreatic cancer relative to other ethnic groups.

It is time to wake up and smell the coffee (roses) -- Study finds; by providing free A1c tests at all check-ups we could find most of those with prediabetes.